WO1991018600A1 - Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3) (pyridil-3)-3 1h,3h-pyrrolo[1,2c] thiazolecarboxamide-7 - Google Patents

Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3) (pyridil-3)-3 1h,3h-pyrrolo[1,2c] thiazolecarboxamide-7

Info

Publication number
WO1991018600A1
WO1991018600A1 PCT/FR1991/000436 FR9100436W WO9118600A1 WO 1991018600 A1 WO1991018600 A1 WO 1991018600A1 FR 9100436 W FR9100436 W FR 9100436W WO 9118600 A1 WO9118600 A1 WO 9118600A1
Authority
WO
WIPO (PCT)
Prior art keywords
thiazolecarboxamide
impending
pyrrolo
pyridyl
benzoyl
Prior art date
Application number
PCT/FR1991/000436
Other languages
English (en)
Other versions
WO1991018600A2 (fr
Inventor
Icilio Cavero
Michel Mestre
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of WO1991018600A1 publication Critical patent/WO1991018600A1/fr
Publication of WO1991018600A2 publication Critical patent/WO1991018600A2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Abstract

Composition pharmaceutique pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le N-(benzoyl-3 phényl) (pyridil-3)-3 1H,3H-pyrrolo-[1,2C] thiazolecarboxamide-7 racémique ou ses énantiomères.
PCT/FR1991/000436 1990-06-01 1991-05-31 Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3) (pyridil-3)-3 1h,3h-pyrrolo[1,2c] thiazolecarboxamide-7 WO1991018600A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR90/06849 1990-06-01
FR9006849A FR2662606A1 (fr) 1990-06-01 1990-06-01 Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3 phenyl) (pyridyl-3)-3 1h,3h-pyrrolo[1,2-c]thiazolecarboxamide-7.

Publications (2)

Publication Number Publication Date
WO1991018600A1 true WO1991018600A1 (fr) 1991-12-12
WO1991018600A2 WO1991018600A2 (fr) 1991-12-12

Family

ID=

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148777A2 (fr) * 1984-01-11 1985-07-17 Takeda Chemical Industries, Ltd. Phospholipides, leur production et utilisation
EP0253711A1 (fr) * 1986-07-04 1988-01-20 Rhone-Poulenc Sante Nouveaux dérivés du 1H,3H-Pyrrolo [1,2-c] thiazole, leur préparation et les Compositions pharmaceutiques qui les contiennent
EP0318235A2 (fr) * 1987-11-25 1989-05-31 Takeda Chemical Industries, Ltd. Composés de pipérazine PAF-antagoniste 1,4-disubstitués et leur production
WO1989012446A1 (fr) * 1988-06-16 1989-12-28 Sumner Burstein Derives de tetrahydrocannabinol utilises en tant qu'antagonistes du facteur d'activation de plaquettes
EP0353777A2 (fr) * 1988-08-04 1990-02-07 J. URIACH & CIA. S.A. Dérivés de la tétra-hydro-furanne substituée sur les positions 2 et 5
EP0353474A2 (fr) * 1988-07-04 1990-02-07 Eisai Co., Ltd. Dérivé de glycérol et son utilisation pharmaceutique
EP0368670A1 (fr) * 1988-11-11 1990-05-16 Takeda Chemical Industries, Ltd. Composés pipéraziniques trisubstitués, leur préparation et leur application

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148777A2 (fr) * 1984-01-11 1985-07-17 Takeda Chemical Industries, Ltd. Phospholipides, leur production et utilisation
EP0253711A1 (fr) * 1986-07-04 1988-01-20 Rhone-Poulenc Sante Nouveaux dérivés du 1H,3H-Pyrrolo [1,2-c] thiazole, leur préparation et les Compositions pharmaceutiques qui les contiennent
EP0318235A2 (fr) * 1987-11-25 1989-05-31 Takeda Chemical Industries, Ltd. Composés de pipérazine PAF-antagoniste 1,4-disubstitués et leur production
WO1989012446A1 (fr) * 1988-06-16 1989-12-28 Sumner Burstein Derives de tetrahydrocannabinol utilises en tant qu'antagonistes du facteur d'activation de plaquettes
EP0353474A2 (fr) * 1988-07-04 1990-02-07 Eisai Co., Ltd. Dérivé de glycérol et son utilisation pharmaceutique
EP0353777A2 (fr) * 1988-08-04 1990-02-07 J. URIACH & CIA. S.A. Dérivés de la tétra-hydro-furanne substituée sur les positions 2 et 5
EP0368670A1 (fr) * 1988-11-11 1990-05-16 Takeda Chemical Industries, Ltd. Composés pipéraziniques trisubstitués, leur préparation et leur application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Pharmacol. Exp. Ther., volume 250, no. 1, 1989, (US), O. Marquis et al.: "Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes", pages 293-300, voir l'abrégé *

Also Published As

Publication number Publication date
ZA914070B (en) 1992-03-25
AU7966991A (en) 1991-12-31
FR2662606A1 (fr) 1991-12-06
IL98305A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
IL74497A0 (en) Pharmaceutical compositions and phenyl carbamate derivatives
CA2182200A1 (fr) Formulations s'appliquant au facteur ix
GB2200109B (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
AU1591792A (en) New dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
GR3036816T3 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
AU2951489A (en) Improving the stability of pharmaceutical compositions
CA2047744A1 (fr) Methode de synthese de l'huperzine a et de ses analogues et composes utilises pour ce faire
ES8506615A1 (es) Un procedimiento para la preparacion de carboxamidas
RU93004860A (ru) Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция
AU9049391A (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
AU628664B2 (en) Cephalosporin compound and pharmaceutical composition thereof
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
CA2139731A1 (fr) 5-hydroxy-1,3 pyrimidines a groupement heterocyclique en position 2 utilises comme agents anti-inflammatoires
AU2660488A (en) 4-heteropentacyclic-4-{N-(phenyl)amido}piperidine derivatives and pharmaceutical compositions and method employing such compounds
NZ239813A (en) Fungicidally active compounds, their methods of production and compositions containing them
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
WO1991018600A1 (fr) Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3) (pyridil-3)-3 1h,3h-pyrrolo[1,2c] thiazolecarboxamide-7
JPS6480287A (en) Novel compound, method for manufacture of the same and drug composition containing the same
AU8844091A (en) Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade
AU5842886A (en) 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
AU1039492A (en) Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA HU JP SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

NENP Non-entry into the national phase

Ref country code: CA